. 510(k) Premarket Notification MAR a Ll 2002 Reposable instrument System
kKolg god Page 1 of 1
———
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS
in Accordance with SMDA of 1990
REPOSABLE INSTRUMENT SYSTEM
December 19, 2001
COMPANY: Aesculap®, Inc.
3773 Corporate Parkway
Center Valley, PA 18034
CONTACT: Lisa M. Millington, Regulatory Associate
800-258-1946 (phone) x5072
610-791-6882 (fax)
, lisa.millington@aesculap.com (email)
»
TRADE NAME: Reposable instrument System
COMMON NAME: Disposable / Reusable Instrurnent System ;
DEVICE CLASS: Class Ul
PRODUCT CODE: GEl
CLASSIFICATION: 878.4800
Device, Electrosurgical, Cutting & Coagulation & Accessories
REVIEW PANEL: General & Plastic Surgery
INTENDED USE
Aesculap's Reposable Instrument System is designed to cut, dissect, manipulate and/or cauterize
various tissue during endoscopic/laparoscopic, general, vascular, gynecological, and thoracic
surgical procedures.
DEVICE DESCRIPTION
Aesculap’s Reposable Instrument System is comprised of non-sterile, reusable handles which are
capable of monopolar electrocautery, via a underside connection terminal, reusable jaw inserts
which come in different sizes and one single use endoscopic scissors. The jaw inserts include the
blades, shaft and locking nut. The reusable scissors insert is supplied non-sterile, and the single
use scissors insert is supplied sterile. The reusable and single use jaw inserts are intended to be
use with either the non-ratcheted or ratcheted handle.
PERFORMANCE DATA
No performance standards have been promulgated under Section 514 of the Food, Drug and
Casmetic Act for these devices. The Reposable Instrument System, however, conform to the
following electromedical standard: [EC/EN 60601-2-2 and IEC/EN 60601-2-18.
SUBSTANTIAL EQUIVALENCE
The Reposable Instrument System are substantially equivalent in their intended use, material
composition, labeling, design and basic operating principles to the following predicate devices:
+  Microline:
+ 3MM Selec-Tip Laparoscopic instrument System (K980758)
+ “Selecta-tip” Laparoscopic Instrument System (K970826)
» Weck’s Endoscopic Instrument System (Disposable/Reusable) (K926203)

tte
, f C. DEPARTMENT OF HEALTH & HUMAN SERVICES : Public Health Service
‘ean SSS .
" / : Food and Drug Administration
/ . . . 9200 Corporate Boulevard
Rockville MD 20850 :
MAR 21 2002
Ms. Lisa M. Millington
Regulatory Associate
Aesculap, Inc.
3773 Corporate Parkway
Center Valley, Pennsylvania 18034
Re: K014207
Trade/Device Name: Reposable Instrument System
Regulation Number: 878.4400
Regulation Name: Electrosurgical, Cutting and Coagulation Devices
and Accessories
Regulatory Class: II
Product Code: GEI
Dated: December 20, 2001
Received: December 21, 2001
Dear Ms. Millington:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
. Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
. or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Ms. Lisa M. Millington : ; /
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and
additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of
Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of
your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the
regulation entitled, "Misbranding by reference to premarket notification” (21CFR Part 807.97).
Other general information on your responsibilities under the Act may be obtained from the
Division of Small Manufacturers, International and Consumer Assistance at its toll-free number
(800) 638-2041 or (301) 443-6597 or at its Internet address
http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Moun C. Carat

A Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

510K) Pretnacket Notification Reposahle Instrument System
. Page 1 of 1
INDICATIONS FOR USE STATEMENT
§10(k) Number (if known): LA $77
Device Name: Reposable Instrument System
indication for Use:
Aesculap's Reposable Instrument System is designed to cut, dissect, manipulate and/or
cauterize various tissue during endoscopicAaproscopic general, vascular, gynecological,
and thoracic surgical procedures.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use a or Over-the-Counter Use
(per 21 CFR 801.109)
(Optional Format 3-10-98)
ivision Sign-Off) .
Civision of General, Restorative
and Neurological Devices
510K) Number -KOl4 20) —

